Member Info for Humpalumps

As long as it's a minimum of 50p by new year I'll be happy - what the SP does on a daily basis I don't really care 🌝

Everyone starts somewhere - I had about 10 grand 3 years ago and that's gone up dramatically from just buying and holding 1 or 2 shares - it doesn't take much to earn a lot on aim you just need to find those low risk high return gems of which there aren't a stupid amount of on AIM but they do exist and this looks like it's shaping up to be one - but I'll let time tell on that 👍

Filled 👍 - I like it - for a mining play there seems to be very little downside

Just put in a FOK for 10 grand at 1.8p will see if it fills

Fitbrokerspal is actually a buy signal - was FUD'ing FAB at 3.5p and history tends to repeat itself so I'm going to look in to this share now to see if I need to buy some 👀

The real question is who would buy this at a 21m mkt cap when there is so much better and less risky plays out there than this

70p by year end is my estimate - NCI validation + one license agreement should get that imo

I get the point and I do agree big pharma ain't going to care about a small company.

But this is patented tech that'll save whoever has exclusive rights to it months on antibody creation due to the humanisation already being done - having exclusive access to that and taking it away from competitors is worth a fortune it's hard to say who wouldn't want this to theirselves tbh

Wow - that is a serious speaker list

If we get confirmation of the optiphage license I think we can skip 20 and just go to 30

Instantly profitable by a long way

Story got much stronger today - follow the story not the candles 👍

Well then they're wrong and will miss out because for formal launch of optimal in December alone will mean around 2-3 RNS's around it beforehand and that's not the only news that's expected between now and December - very bullish period were in right now

Reply around the optimal library on the investor hub - pretty much it's a one stop shop but for obvious reasons he can't really say it is.

The extent of the library, because it mimics the human immunome, is also vast being approximately 10^45 possible sequences: in words that’s a billion, trillion, trillion, trillion sequences. Within that scope it holds enormous potential to provide antibodies for a very wide range of therapeutic, as well as diagnostic and research applications. However, we would draw short of a blanket statement that it is a panacea that can solve all antibody needs.

Have to remember this patent is for library and methodology so it's almost 2 patents in 1

So considering optimal has a much, much larger library, humanises as part of it and is patented (unsure if that one is you've mentioned)

So basically we're looking at a complete baseline of around 100m usd and that's just one of their platforms 😍

'further' outlicensing partners 👀

Hopefully this is the start of the news period having this patent - the NCI validation can come when it comes but realistically FAB should have an idea of it's commercial value and would be why they're showing it off at events now - wouldn't make sense to show it off if you don't know it's commercially viable

Don't forget their have AIMLab too 👍

I'll say wow when we're in triple digits tbh - optimal is a complete game changer.

1 license agreement on that and we really need to start looking at high double digits tbh

Well that library is about to patent protected too 👀